Clinical Trial CTSUTHOC30607-M
Title
ARandomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer
Principal Investigator(s)
John Murray
Details
- Protocol No. CTSUTHOC30607-M
- Open Date: 02/17/2010
- Staging: Phase III
- Age Group: Adults
- Scope: National
- Objective:
- Disease Sites:
- Therapies: Molecular Targeted Agents / Immunotherapy / Biologics
- Drugs: None Specified
- Participating Institutions: Meharry Medical College
- Secondary Protocol No: Not Specified
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
